References

  1. Global tuberculosis report 2024. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/379339). Licence: CC BY-NC-SA 3.0 IGO.
  2. Li A, Yuan SY, Li QG, Li JX, Yin XY, Liu NN. Prevalence and risk factors of malnutrition in patients with pulmonary tuberculosis: a systematic review and meta-analysis. Front Med. 2023;10:1173619 (https://doi.org/10.3389/fmed.2023.1173619).
  3. Franco JV, Bongaerts B, Metzendorf MI, Risso A, Guo Y, Pena Silva L et al. Undernutrition as a risk factor for tuberculosis disease. Cochrane Database Syst Rev. 2024;6:CD015890 (https://doi.org/10.1002/14651858.CD015890.pub2).
  4. Sinha P, Ponnuraja C, Gupte N, Prakash Babu S, Cox SR, Sarkar S et al. Impact of undernutrition on tuberculosis treatment outcomes in India: a multicenter, prospective, cohort analysis. Clin Infect Dis. 2023;76:1483–91 (https://doi.org/10.1093/cid/ciac915).
  5. Wagnew F, Alene KA, Kelly M, Gray D. The effect of undernutrition on sputum culture conversion and treatment outcomes among people with multidrug-resistant tuberculosis: a systematic review and meta-analysis. Int J Infect Dis. 2023;127:93–105 (https://doi.org/10.1016/j.ijid.2022.11.043).
  6. Lonnroth K, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol. 2010;39:149–55 (https://doi.org/10.1093/ije/dyp308).
  7. Bhargava A, Bhargava M, Meher A, Benedetti A, Velayutham B, Sai Teja G et al. Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial. Lancet. 2023;402:627–40 (https://doi.org/10.1016/S0140-6736(23)01231-X).
  8. The End TB Strategy. Geneva: World Health Organization; 2015 (https://apps.who.int/iris/handle/10665/331326).
  9. Political declaration on the high-level meeting on the fight against tuberculosis “Advancing science, finance and innovation, and their benefits, to urgently end the global tuberculosis epidemic, in particular by ensuring equitable access to prevention, testing, treatment and care”. New York, NY: United Nations; 2023 (https://documents.un.org/doc/undoc/gen/n23/306/91/pdf/n2330691.pdf).
  10. Sinha P, Lonnroth K, Bhargava A, Heysell SK, Sarkar S, Salgame P et al. Food for thought: addressing undernutrition to end tuberculosis. Lancet Infect Dis. 2021;21:e318–25 (https://doi.org/10.1016/S1473-3099(20)30792-1).
  11. Guideline: nutritional care and support for patients with tuberculosis. Geneva: World Health Organization; 2013 (https://iris.who.int/handle/10665/94836).
  12. WHO consolidated guidelines on tuberculosis. Module 2: screening – systematic screening for tuberculosis disease. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/340255). Licence: CC BY-NC-SA 3.0 IGO.
  13. WHO handbook for guideline development, 2nd ed. Geneva: World Health Organization; 2014 (https://iris.who.int/handle/10665/145714).
  14. Framework for collaborative action on tuberculosis and comorbidities. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/361989). Licence: CC BY-NC-SA 3.0 IGO.
  15. WHO TB Knowledge Sharing Platform [website]. Geneva: World Health Organization; 2025 (https://tbksp.who.int/en).
  16. Blackburn GL. Nutritional assessment and support during infection. Am J Clin Nutr. 1977;30:1493–7 (https://doi.org/10.1093/ajcn/30.9.1493).
  17. AHA Physician Alliance [website]. Sioux Falls, SD: American Hospital Association Physician Alliance; 2025 (https://www.aha.org/aha-physician-alliance).
  18. World Food Programme, United Nations Programme on HIV/AIDS (UNAIDS), U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). Nutrition assessment, counselling and support for adolescents and adults living with HIV – a programming guide. Rome: World Food Programme; 2014 (https://documents.wfp.org/stellent/groups/public/documents/newsroom/wfp271543.pdf).
  19. Farazi A, Shafaat O, Sofian M, Kahbazi M. Arginine adjunctive therapy in active tuberculosis. Tuberc Res Treat. 2015;2015:205016 (https://doi.org/10.1155/2015/205016).
  20. Schon T, Idh J, Westman A, Elias D, Abate E, Diro E et al. Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis – a randomised trial. Tuberculosis (Edinb). 2011;91:370–7 (https://doi.org/10.1016/j.tube.2011.06.002).
  21. Ma’rufi I, Ali K, Jati SK, Sukmawati A, Ardiansyah K, Ningtyias FW. Improvement of nutritional status among tuberculosis patients by channa striata supplementation: a true experimental study in Indonesia. Biomed Res Int. 2020;2020:7491702 (https://doi.org/10.1155/2020/7491702).
  22. Nenni V, Nataprawira HM, Yuniati T. Role of combined zinc, vitamin A, and fish oil supplementation in childhood tuberculosis. Southeast Asian J Trop Med Public Health. 2013;44:854–61 (https://pubmed.ncbi.nlm.nih.gov/24437320/).
  23. Sudarsanam TD, John J, Kang G, Mahendri V, Gerrior J, Franciosa M et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV-tuberculosis coinfection receiving directly observed short-course chemotherapy for tuberculosis. Trop Med Int Health. 2011;16:699–706 (https://doi.org/10.1111/j.1365-3156.2011.02761.x).
  24. PrayGod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Aabye MG et al. The effect of energy-protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV-co-infected patients: randomised controlled trial in Mwanza, Tanzania. Br J Nutr. 2012;107:263–71 (https://doi.org/10.1017/s0007114511002832).
  25. Jahnavi G, Sudha CH. Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Med J. 2010;51:957–62 (https://pubmed.ncbi.nlm.nih.gov/21221502/).
  26. Paton NI, Chua YK, Earnest A, Chee CB. Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. Am J Clin Nutr. 2004;80:460–5 (https://doi.org/10.1093/ajcn/80.2.460).
  27. Xu Y. Investigation on the nutritional status and nutritional therapy in 398 patients with tuberculosis. J Chin Antituberc. 2008;30:335–7; (in Chinese).
  28. Martins N, Morris P, Kelly PM. Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor-Leste. BMJ. 2009;339:b4248. (https://doi.org/10.1136/bmj.b4248). Erratum in: BMJ. 2016 May 27;353:i3039. (https://doi.org/10.1136/bmj.b4248).
  29. Baldwin C, de van der Schueren MA, Kruizenga HM, Weekes CE. Dietary advice with or without oral nutritional supplements for disease-related malnutrition in adults. Cochrane Database Syst Rev. 2021;12:Cd002008 (https://doi.org/10.1002/14651858.CD002008.pub5).
  30. Munk T, Tolstrup U, Beck AM, Holst M, Rasmussen HH, Hovhannisyan K et al. Individualised dietary counselling for nutritionally at-risk older patients following discharge from acute hospital to home: a systematic review and meta-analysis. J Hum Nutr Diet. 2016;29:196–208 (https://doi.org/10.1111/jhn.12307).
  31. James S, Oppermann A, Schotz KM, Minotti MM, Rao GG, Kleckner IR et al. Nutritional counseling during chemotherapy treatment: a systematic review of feasibility, safety, and efficacy. Curr Oncol. 2024;32:3 (https://pubmed.ncbi.nlm.nih.gov/39851919/).
  32. Bhargava A, Bhargava M, Meher A, Teja GS, Velayutham B, Watson B et al. Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India. Lancet Glob Health. 2023;11:e1402–e11 (https://doi.org/10.1016/S2214-109X(23)00324-8).
  33. Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries. Geneva: World Health Organization; 2012 (https://iris.who.int/handle/10665/77741).
  34. WHO guideline on the prevention and management of wasting and nutritional oedema (acute malnutrition) in infants and children under 5 years. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/376075). Licence: CC BY-NC-SA 3.0 IGO.
  35. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva: World Health Organization; 2016 (https://iris.who.int/handle/10665/250796).
  36. Integrated care for older people: guidelines on community-level interventions to manage declines in intrinsic capacity. Geneva: World Health Organization; 2017 (https://iris.who.int/handle/10665/258981). Licence: CC BY-NC-SA 3.0 IGO.
  37. WHO recommendations on maternal and newborn care for a positive postnatal experience. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/352658). Licence: CC BY-NC-SA 3.0 IGO.
  38. IMAI district clinician manual: hospital care for adolescents and adults: guidelines for the management of illnesses with limited-resources. Geneva: World Health Organization; 2012 (https://iris.who.int/handle/10665/77751).
  39. World Health Organization, UNHCR, World Food Programme, United Nations Children’s Fund. Food and nutrition needs in emergencies. Geneva: World Health Organization; 2004 (https://iris.who.int/handle/10665/68660).
  40. World Health Organization, United Nations Children’s Fund. WHO child growth standards and the identification of severe acute malnutrition in infants and children : joint statement by the World Health Organization and the United Nations Children’s Fund. Geneva: World Health Organization; 2009 (https://iris.who.int/handle/10665/44129).
  41. Malnutrition [website]. Geneva: World Health Organization; 2025 (https://www.who.int/health-topics/malnutrition).
  42. The Food Insecurity Experience Scale (FIES) [website]. Rome: Food and Agriculture Organization of the United Nations; 2025 (https://www.fao.org/in-action/voices-of-the-hungry/fies/en/).
  43. Bhargava M, Bhargava A, Akshaya KM, Shastri SG, Bairy R, Parmar M et al. Nutritional assessment and counselling of tuberculosis patients at primary care in India: do we measure up? Int J Tuberc Lung Dis. 2019;23:147–50 (https://doi.org/10.5588/ijtld.18.0333).
  44. Zachariah R, Spielmann MP, Harries AD, Gomani P, Graham SM, Bakali E et al. Passive versus active tuberculosis case finding and isoniazid preventive therapy among household contacts in a rural district of Malawi. Int J Tuberc Lung Dis. 2003;7:1033–9 (https://pubmed.ncbi.nlm.nih.gov/14598961/).
  45. Baik Y, Hanrahan CF, Mmolawa L, Nonyane BAS, Albaugh NW, Lebina L et al. Conditional cash transfers to incentivize tuberculosis screening: description of a novel strategy for contact investigation in rural South Africa. Clin Infect Dis. 2022;74:957–64 (https://doi.org/10.1093/cid/ciab601).
  46. WHO consolidated guidelines on tuberculosis. Module 1: prevention – tuberculosis preventive treatment, second edition. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/378536). Licence: CC BY-NC-SA 3.0 IGO.
  47. Baral SC, Aryal Y, Bhattrai R, King R, Newell JN. The importance of providing counselling and financial support to patients receiving treatment for multi-drug resistant TB: mixed method qualitative and pilot intervention studies. BMC Public Health. 2014;14:46 (https://doi.org/10.1186/1471-2458-14-46).
  48. He L, Zhang G, Wei M, Zhao Y, Chen W, Peng Q et al. Effect of individualized dietary intervention on oxidative stress in patients with type 2 diabetes complicated by tuberculosis in Xinjiang, China. Diabetes Ther. 2019;10:2095–105 (https://doi.org/10.1007/s13300-019-00691-2).
  49. Honarvar MR, Eghtesadi S, Gill P, Jazayeri S, Vakili MA, Shamsardekani MR et al. The effect of green tea extract supplementation on sputum smear conversion and weight changes in pulmonary TB patients: a randomized controlled trial. Med J Islam Repub Iran. 2016;30:381 (https://pmc.ncbi.nlm.nih.gov/articles/PMC4972068/).
  50. Jeremiah K, Denti P, Chigutsa E, Faurholt-Jepsen D, PrayGod G, Range N et al. Nutritional supplementation increases rifampin exposure among tuberculosis patients coinfected with HIV. Antimicrob Agents Chemother. 2014;58:3468–74 (https://doi.org/10.1128/aac.02307-13).
  51. Pérez-Guzmán C, Vargas MH, Quiñonez F, Bazavilvazo N, Aguilar A. A cholesterol-rich diet accelerates bacteriologic sterilization in pulmonary tuberculosis. Chest. 2005;127:643–51 (https://doi.org/10.1378/chest.127.2.643).
  52. Ralph AP, Waramori G, Pontororing GJ, Kenangalem E, Wiguna A, Tjitra E et al. L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial. PLoS One. 2013;8:e70032 (https://doi.org/10.1371/journal.pone.0070032).
  53. Reis-Santos B, Locatelli R, Oliosi J, Sales CM, do Prado TN, Shete PB et al. A matter of inclusion: a cluster-randomized trial to access the effect of food vouchers versus traditional treatment on tuberculosis outcomes in Brazil. Am J Trop Med Hyg. 2022;107:1281–7 (https://doi.org/10.4269/ajtmh.21-1074).
  54. Schon T, Elias D, Moges F, Melese E, Tessema T, Stendahl O et al. Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis. Eur Respir J. 2003;21:483–8 (https://doi.org/10.1183/09031936.03.00090702).
  55. Florentino JL, Arao RML, Garfin AMC, Gaviola DMG, Tan CR, Yadav RP et al. Expansion of social protection is necessary towards zero catastrophic costs due to TB: the first national TB patient cost survey in the Philippines. PLoS One. 2022;17:e0264689 (https://www.doi.org/10.1371/journal.pone.0264689).
  56. Chittamany P, Yamanaka T, Suthepmany S, Sorsavanh T, Siphanthong P, Sebert J et al. First national tuberculosis patient cost survey in Lao People’s Democratic Republic: assessment of the financial burden faced by TB-affected households and the comparisons by drug-resistance and HIV status. PLoS One. 2020;15:e0241862 (https://doi.org/10.1371/journal.pone.0241862).
  57. Viney K, Amaral S, Marques EB, Siroka A, Lopes C, Nery SV. Four of five tuberculosis patients experience catastrophic costs related to TB diagnosis and care in Timor-Leste. Int J Tuberc Lung Dis. 2019;23:1191–7 (https://doi.org/10.5588/ijtld.18.0765).
  58. Fuady A, Houweling TAJ, Mansyur M, Burhan E, Richardus JH. Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: eight simulated scenarios. Infect Dis Poverty. 2019;8:10 (https://doi.org/10.1186/s40249-019-0519-7).
  59. Madan JJ, Rosu L, Tefera MG, van Rensburg C, Evans D, Langley I et al. Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial. Bull World Health Organ. 2020;98:306–14 (https://doi.org/10.2471/BLT.19.243584).
  60. WHO consolidated guidelines on tuberculosis. Module 4: treatment – drug-resistant tuberculosis treatment, 2022 update. Geneva: World Health Organization; 2022 (https://apps.who.int/iris/handle/10665/365308). Licence: CC BY-NC-SA 3.0 IGO.
  61. WHO consolidated guidelines on tuberculosis. Module 4: treatment and care. Geneva: World Health Organization; 2025 (https://iris.who.int/handle/10665/380799).
  62. McQuaid CF, Clark RA, White RG, Bakker R, Alexander P, Henry R et al. Estimating the epidemiological and economic impact of providing nutritional care for tuberculosis-affected households across India: a modelling study. Lancet Glob Health. 2025;13:e488–96 (https://doi.org/10.1016/S2214-109X(24)00505-9).
  63. Benzekri NA, Sambou JF, Tamba IT, Diatta JP, Sall I, Cisse O et al. Nutrition support for HIV-TB co-infected adults in Senegal, West Africa: a randomized pilot implementation study. PLoS One. 2019;14:e0219118 (https://doi.org/10.1371/journal.pone.0219118).
  64. Ukwaja KN, Alobu I, Mustapha G, Onazi O, Oshi DC. ‘Sustaining the DOTS’: stakeholders’ experience of a social protection intervention for TB in Nigeria. Int Health. 2017;9:112–7 (https://doi.org/10.1093/inthealth/ihx001).
  65. Lutge E, Lewin S, Volmink J, Friedman I, Lombard C. Economic support to improve tuberculosis treatment outcomes in South Africa: a pragmatic cluster-randomized controlled trial. Trials. 2013;14:154 (https://doi.org/10.1186/1745-6215-14-154).
  66. Sinclair D, Abba K, Grobler L, Sudarsanam TD. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev. 2011:CD006086 (https://doi.org/10.1002/14651858.CD006086.pub3).
  67. Dobler CC, Korver S, Batbayar O, Oyuntsetseg S, Tsolmon B, Wright C et al. Success of community-based directly observed anti-tuberculosis treatment in Mongolia. Int J Tuberc Lung Dis. 2015;19:657–62 (https://doi.org/10.5588/ijtld.14.0927).
  68. Ngamvithayapong-Yanai J, Luangjina S, Nedsuwan S, Kantipong P, Wongyai J, Ishikawa N. Engaging women volunteers of high socioeconomic status in supporting socioeconomically disadvantaged tuberculosis patients in Chiang Rai, Thailand. Western Pac Surveill Response J. 2013;4:34–8 (https://doi.org/10.5365/WPSAR.2012.3.4.013).
  69. Zou G, Wei X, Witter S, Yin J, Walley J, Liu S et al. Incremental cost-effectiveness of improving treatment results among migrant tuberculosis patients in Shanghai. Int J Tuberc Lung Dis. 2013;17:1056–64 (https://doi.org/10.5588/ijtld.12.0799).
  70. Lu H, Yan F, Wang W, Wu L, Ma W, Chen J et al. Do transportation subsidies and living allowances improve tuberculosis control outcomes among internal migrants in urban Shanghai, China? Western Pac Surveill Response J. 2013;4:19–24 (https://ojs.wpro.who.int/ojs/index.php/wpsar/article/view/187).
  71. Wei X, Zou G, Yin J, Walley J, Yang H, Kliner M et al. Providing financial incentives to rural-to-urban tuberculosis migrants in Shanghai: an intervention study. Infect Dis Poverty. 2012;1:9 (https://doi.org/10.1186/2049-9957-1-9).
  72. Cantalice Filho JP. Food baskets given to tuberculosis patients at a primary health care clinic in the city of Duque de Caxias, Brazil: effect on treatment outcomes. J Bras Pneumol. 2009;35:992–7 (https://doi.org/10.1590/s1806-37132009001000008).
  73. Sripad A, Castedo J, Danford N, Zaha R, Freile C. Effects of Ecuador’s national monetary incentive program on adherence to treatment for drug-resistant tuberculosis. Int J Tuberc Lung Dis. 2014;18:44–8 (https://doi.org/10.5588/ijtld.13.0253).
  74. Tsai WC, Kung PT, Khan M, Campbell C, Yang WT, Lee TF et al. Effects of pay-for-performance system on tuberculosis default cases control and treatment in Taiwan. J Infect. 2010;61:235–43 (https://doi.org/10.1016/j.jinf.2010.06.016).
  75. Bock NN, Sales RM, Rogers T, DeVoe B. A spoonful of sugar... improving adherence to tuberculosis treatment using financial incentives. Int J Tuberc Lung Dis. 2001;5:96–8 (https://pubmed.ncbi.nlm.nih.gov/11263524/).
  76. National surveys of costs faced by tuberculosis patients and their households 2015–2021. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/366277). Licence: CC BY-NC-SA 3.0 IGO.
  77. Sinha P, Lakshminarayanan SL, Cintron C, Narasimhan PB, Locks LM, Kulatilaka N et al. Nutritional supplementation would be cost-effective for reducing tuberculosis incidence and mortality in India: The Ration Optimization to Impede Tuberculosis (ROTI-TB) Model. Clin Infect Dis. 2022;75:577–85 (https://doi.org/10.1093/cid/ciab1033).
  78. Bandewar SS, Bhargava M, Pisal H, Sreekumar S, Bhan A, Meher A et al. Qualitative study of acceptability, benefits, and feasibility of a food-based intervention among participants and stakeholders of the RATIONS trial. PLOS Glob Public Health. 2025;5:e0004219 (https://doi.org/10.1371/journal.pgph.0004219).
  79. Hunger and food insecurity [website]. Rome: Food and Agriculture Organization of the United Nations; 2025 (https://www.fao.org/hunger/en).
  80. FAOSTAT [website]. Rome: Food and Agriculture Organization of the United Nations; 2025 (https://www.fao.org/faostat/en/#data/FS).
  81. FAO Hunger Map [website]. Rome: Food and Agriculture Organization of the United Nations; 2025 (https://www.fao.org/interactive/state-of-food-security-nutrition/2-1-1/en/).
  82. Poblacion A, Segall-Correa AM, Cook J, Taddei J. Validity of a 2-item screening tool to identify families at risk for food insecurity in Brazil. Cad Saude Publica. 2021;37:e00132320 (https://doi.org/10.1590/0102-311X00132320).
  83. Baker S, Gallegos D, Rebuli MA, Taylor AJ, Mahoney R. Food insecurity screening in high-income countries, tool validity, and implementation: a scoping review. Nutrients. 2024;16 (https://doi.org/10.3390/nu16111684).
  84. Integrated Food Security Phase Classification [website]. Rome: IPC; 2025 (https://www.ipcinfo.org/).
  85. WHO standard: universal access to rapid tuberculosis diagnostics. Geneva: World Health Organization; 2023 (https://iris.who.int/handle/10665/366854). Licence: CC BY-NC-SA 3.0 IGO.
  86. World Health Organization, International Labour Organization. Guidance on social protection for people affected by tuberculosis. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/376542). Licence: CC BY-NC-SA 3.0 IGO.
  87. Food and Agriculture Organization of the United Nations, World Health Organization. Standard for the labelling of and claims for foods for special medical purposes CODEX STAN 180-1991. Rome: Food and Agriculture Organization of the United Nations; 1991 (https://www.fao.org/fao-who-codexalimentarius/sh-proxy/ar/?lnk=1&url=https%253A%252F%252Fworkspace.fao.org%252Fsites%252Fcodex%252FStandards%252FCXS%2B180-1991%252FCXS_180e.pdf).
  88. Food and Agriculture Organization of the United Nations, World Health Organization. General standard for the labelling of and claims for prepackaged foods for special dietary uses CODEX STAN 146-1985. Rome: Food and Agriculture Organization of the United Nations; 1985 (https://www.fao.org/4/y2770e/y2770e04.htm).
  89. The food WFP delivers [website]. Washington, DC: World Food Program USA; 2025 (https://www.wfpusa.org/food-we-deliver/).
  90. The WFP food basket [website]. Rome: World Food Programme; 2025 (https://www.wfp.org/wfp-food-basket).
  91. Mayo Clinic. L-arginine [website]. 2024 (https://www.mayoclinic.org/drugs-supplements-l-arginine/art-20364681).
  92. GSMA and UN World Food Programme accelerate the use of mobile financial services for humanitarian assistance. Rome: World Food Programme; 2020 (https://www.wfp.org/news/gsma-and-un-world-food-programme-accelerate-use-mobile-financial-services-humanitarian).
  93. Building Blocks [website]. Rome: World Food Programme; 2025 (https://innovation.wfp.org/project/building-blocks).
  94. Doherty AM, Kelly J, McDonald C, O’Dywer AM, Keane J, Cooney J. A review of the interplay between tuberculosis and mental health. Gen Hosp Psychiatry. 2013;35:398–406 (https://doi.org/10.1016/j.genhosppsych.2013.03.018).
  95. Sweetland AC, Kritski A, Oquendo MA, Sublette ME, Norcini Pala A, Silva LRB et al. Addressing the tuberculosis-depression syndemic to end the tuberculosis epidemic. Int J Tuberc Lung Dis. 2017;21:852–61 (https://doi.org/10.5588/ijtld.16.0584).
  96. WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities, third edition. 2024 (https://iris.who.int/handle/10665/380063). Licence: CC BY-NC-SA 3.0 IGO.
  97. Pasha A, Siddiqui H, Ali S, Brooks MB, Maqbool NR, Khan AJ. Impact of integrating mental health services within existing tuberculosis treatment facilities. Med Access Point Care. 2021;5:23992026211011314 (https://doi.org/10.1177/23992026211011314).
  98. Range N, Andersen AB, Magnussen P, Mugomela A, Friis H. The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomized controlled trial in Mwanza, Tanzania. Trop Med Int Health. 2005;10:826–32 (https://doi.org/10.1111/j.1365-3156.2005.01463.x).
  99. Seyedrezazadeh E, Ostadrahimi A, Mahboob S, Assadi Y, Ghaemmagami J, Pourmogaddam M. Effect of vitamin E and selenium supplementation on oxidative stress status in pulmonary tuberculosis patients. Respirology. 13:294–8 (https://doi.org/10.1111/j.1440-1843.2007.01200.x).
  100. Mehta S, Mugusi FM, Bosch RJ, Aboud S, Chatterjee A, Finkelstein JL et al. A randomized trial of multivitamin supplementation in children with tuberculosis in Tanzania. FASEB J. 2010;24 (https://doi.org/10.1186/1475-2891-10-120).
  101. Afzal A, Rathore R, Butt NF, Randhawa FA. Efficacy of vitamin D supplementation in achieving an early sputum conversion in smear positive pulmonary tuberculosis. Pak J Med Sci. 2018;34:849–54 (https://pubmed.ncbi.nlm.nih.gov/30190740/).
  102. Ahmad I, Al-Ahmare K. Effect of vitamin A and zinc on circulating profile of IL-2, IL-12, and IFNγ cytokines in pulmonary tuberculosis patients. Int J Nutr Pharmacol Neurol Dis. 2016;6:63–71 (https://journals.lww.com/ijnp/fulltext/2016/06020/effect_of_vitamin_a_and_zinc_on_circulating.2.aspx).
  103. Armijos RX, Weigel MM, Chacon R, Flores L, Campos A. Adjunctive micronutrient supplementation for pulmonary tuberculosis. Salud Publica Mex. 2010;52:185–9 (https://pubmed.ncbi.nlm.nih.gov/20485880/).
  104. Daley P, Jagannathan V, John KR, Sarojini J, Latha A, Vieth R et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2015;15:528–34 (https://doi.org/10.1016/s1473-3099(15)70053-8).
  105. Farazi A, Didgar F, Sarafraz A. The effect of vitamin D on clinical outcomes in tuberculosis. Egypt J Chest Dis Tuberc. 2017;66:419-23 (https://doi.org/10.1016/j.ejcdt.2017.01.004).
  106. Ganmaa D, Munkhzul B, Fawzi W, Spiegelman D, Willett WC, Bayasgalan P et al. High-dose vitamin D(3) during tuberculosis treatment in Mongolia. a randomized controlled trial. Am J Respir Crit Care Med. 2017;196:628–37 (https://doi.org/10.1164/rccm.201705-0936OC).
  107. Ginawi IA, Ahmed MQ, Ahmad I, Al-Hazimi AM. Effect of zinc and vitamin a supplementation along with inter-tubercular treatment in pulmonary tuberculosis in North Indian patients. Int J Pharm Sci Res. 2013;4:3426–31 (https://doi.org/10.13040/IJPSR.0975-8232.4(9).3426-31).
  108. Hasanain AFA, Zayed AAH, Abd-Ellatief RB, Nafee AMA. Efficacy and safety of cholecalciferol-augmented anti-tuberculosis therapy for treatment of naïve patients with pulmonary tuberculosis: a randomized, controlled, clinical study. Indian J Tuberc. 2019;66:111–7 (https://doi.org/10.1016/j.ijtb.2018.06.004).
  109. Hussain MI, Ahmed W, Nasir M, Mushtaq MH, Sheikh AA, Shaheen AY et al. Immune modulatory and anti-oxidative effect of selenium against pulmonary tuberculosis. Pak J Pharm Sci. 2019;32:779–84 (https://pubmed.ncbi.nlm.nih.gov/31103972/).
  110. Karyadi E, West CE, Schultink W, Nelwan RH, Gross R, Amin Z et al. A double-blind, placebo-controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. Am J Clin Nutr. 2002;75:720–7 (https://doi.org/10.1093/ajcn/75.4.720).
  111. Kota SK, Jammula S, Kota SK, Tripathy PR, Panda S, Modi KD. Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes Metab Syndr. 2011;5:85–9 (https://doi.org/10.1016/j.dsx.2012.02.021).
  112. Kr Singh A, Gogoi JB, Pant NC, Mittal P, Juyal V, Mukherjee S. A study on the role of vitamins and minerals supplementation in the treatment of tuberculosis. Indian J Public Health Res Dev. 2013;4:26–30 (https://doi.org/10.5958/j.0976-5506.4.2.006).
  113. Kumar B, Praveen D, Ranadheer Chowdary P, Vijey Aanandhi M A. Prospective single-blinded study on the safety and efficacy of zinc supplementation in pulmonary tuberculosis [prospective single-blinded study on safety and efficacy of cholecalciferol supplementation in pulmonary tuberculosis). Asian J Pharm Clin Res. 2018;11:90–4 (https://doi.org/10.22159/ajpcr.2018.v11s4.31685).
  114. Lawson L, Thacher TD, Yassin MA, Onuoha NA, Usman A, Emenyonu NE et al. Randomized controlled trial of zinc and vitamin A as co-adjuvants for the treatment of pulmonary tuberculosis. Trop Med Int Health. 2010;15:1481–90 (https://doi.org/10.1111/j.1365-3156.2010.02638.x).
  115. Lodha R, Mukherjee A, Singh V, Singh S, Friis H, Faurholt-Jepsen D et al. Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. Am J Clin Nutr. 2014;100:1287–97 (https://doi.org/10.3945/ajcn.113.082255).
  116. Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet. 2011;377:242–50 (https://doi.org/10.1016/s0140-6736(10)61889-2).
  117. Mily A, Rekha RS, Kamal SM, Arifuzzaman AS, Rahim Z, Khan L et al. Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial. PLoS One. 2015;10:e0138340 (https://doi.org/10.1371/journal.pone.0138340).
  118. Pakasi TA, Karyadi E, Suratih NM, Salean M, Darmawidjaja N, Bor H et al. Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia. Nutr J. 2010;9:41 (https://doi.org/10.1186/1475-2891-9-41).
  119. PrayGod G, Range N, Faurholt-Jepsen D, Jeremiah K, Faurholt-Jepsen M, Aabye MG et al. Daily multi-micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV-uninfected but not HIV-infected patients in Mwanza, Tanzania. J Nutr. 2011;141:685–91 (https://doi.org/10.3945/jn.110.131672).
  120. Salahuddin N, Ali F, Hasan Z, Rao N, Aqeel M, Mahmood F. Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis. BMC Infect Dis. 2013;13:22 (https://doi.org/10.1186/1471-2334-13-22).
  121. Semba RD, Kumwenda J, Zijlstra E, Ricks MO, van Lettow M, Whalen C et al. Micronutrient supplements and mortality of HIV-infected adults with pulmonary TB: a controlled clinical trial. Int J Tuberc Lung Dis. 2007;11:854–9 (https://pubmed.ncbi.nlm.nih.gov/17705950/).
  122. Sinha S, Thukral H, Shareef I, Desai D, Singh BK, Das BK et al. Prevention of relapse in drug sensitive pulmonary tuberculosis patients with and without vitamin D3 supplementation: A double blinded randomized control clinical trial. PLoS One. 2023;18:e0272682 (https://doi.org/10.1371/journal.pone.0272682).
  123. Tamara L, Kartasasmita CB, Alam A, Gurnida DA. Effects of vitamin D supplementation on resolution of fever and cough in children with pulmonary tuberculosis: a randomized double-blind controlled trial in Indonesia. J Glob Health. 2022;12:04015 (https://doi.org/10.7189/jogh.12.04015).
  124. Tukvadze N, Sanikidze E, Kipiani M, Hebbar G, Easley KA, Shenvi N et al. High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial. Am J Clin Nutr. 2015;102:1059–69 (https://doi.org/10.3945/ajcn.115.113886).
  125. Visser ME, Grewal HM, Swart EC, Dhansay MA, Walzl G, Swanevelder S et al. The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial. Am J Clin Nutr. 2011;93:93–100–93– (https://doi.org/10.3945/ajcn.110.001784).
  126. Wang J, Xiong K, Wang Q, Zhao S, Liu Y, Ma A. Adjunctive vitamin A and D during pulmonary tuberculosis treatment: a randomized controlled trial with a 2 × 2 factorial design. Food Funct. 2020;11:4672–81 (https://doi.org/10.1039/c9fo02751c).
  127. Wejse C, Gomes VF, Rabna P, Gustafson P, Aaby P, Lisse IM et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2009;179:843–50 (https://doi.org/10.1164/rccm.200804-567OC).
  128. Wen Y, Li L, Deng Z. Calcitriol supplementation accelerates the recovery of patients with tuberculosis who have vitamin D deficiency: a randomized, single-blind, controlled clinical trial. BMC Infect Dis. 2022;22:436 (https://doi.org/10.1186/s12879-022-07427-x).
  129. Zhang L, Wang S, Zhu Y, Yang T. Vitamin D3 as adjunctive therapy in the treatment of depression in tuberculosis patients: a short-term pilot randomized double-blind controlled study. Neuropsychiatr Dis Treat. 2018;14:3103–9 (https://doi.org/10.2147/ndt.S183039).
  130. Zolfaghari B, Ghanbari M, Musavi H, Bavandpour Baghshahi P, Taghikhani M, Pourfallah F. Investigation of zinc supplement impact on the serum biochemical parameters in pulmonary tuberculosis: a double blinded placebo control trial. Rep Biochem Mol Biol. 2021;10:173–82 (https://doi.org/10.52547/rbmb.10.2.173).
  131. Hanekom WA, Potgieter S, Hughes EJ, Malan H, Kessow G, Hussey GD. Vitamin A status and therapy in childhood pulmonary tuberculosis. J Pediatr. 1997;131:925–7 (https://doi.org/10.1016/s0022-3476(97)70046-5).
  132. Hasanain AFA, Zayed AAH, Mahdy RE, Nafee AMA. Cholecalciferol for prophylaxis against antituberculosis therapy-induced liver disorders among naïve patients with pulmonary tuberculosis: a randomized, comparative study. Int J Mycobact. 2017;6:149–55 (https://pubmed.ncbi.nlm.nih.gov/28559516/).
  133. Sinha S, Thukral H, Shareef I, Dhooria S, Behera D, Bala S et al. Prevention of relapse in category I treated pulmonary tuberculosis patients with and without vitamin D3 supplementation: a double blinded randomized control clinical trial. Am J Respir Crit Care Med. 2022;205 (https://doi.org/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A4926).
  134. Xiong K, Wang J, Ma A. Adjunctive vitamin A and D for the glycaemic control in patients with concurrent type 2 diabetes and tuberculosis: a randomised controlled trial. Br J Nutr. 2022;127:556–62 (https://doi.org/10.1017/S0007114521001185).
  135. WHO operational handbook on tuberculosis. Module 4: treatment and care. Geneva: World Health Organization; 2025 (https://iris.who.int/handle/10665/381095).
  136. Chandra RK. Nutrient supplementation as adjunct therapy in pulmonary tuberculosis. Int J Vitam Nutr Res. 2004;74:144–6 (https://doi.org/10.1024/0300-9831.74.2.144).
  137. Villamor E, Mugusi F, Urassa W, Bosch RJ, Saathoff E, Matsumoto K et al. A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis. J Infect Dis. 2008;197:1499–505 (https://doi.org/10.1086/587846).
  138. WHO antenatal care recommendations for a positive pregnancy experience. Nutritional interventions update: multiple micronutrient supplements during pregnancy. Geneva: World Health Organization; 2020 (https://iris.who.int/handle/10665/333561). Licence: CC BY-NC-SA 3.0 IGO.
  139. WHO antenatal care recommendations for a positive pregnancy experience. Nutritional interventions update: vitamin D supplements during pregnancy. Geneva: World Health Organization; 2020 (https://iris.who.int/handle/10665/333562). Licence: CC BY-NC-SA 3.0 IGO.
  140. WHO antenatal care recommendations for a positive pregnancy experience. Nutritional interventions update: zinc supplements during pregnancy. Geneva: World Health Organization; 2021 (https://iris.who.int/handle/10665/344010). Licence: CC BY-NC-SA 3.0 IGO.
  141. Guidelines on optimal feeding of low birth-weight infants in low- and middle-income countries. Geneva: World Health Organization; 2011 (https://iris.who.int/handle/10665/85670).
  142. Guideline: fortification of wheat flour with vitamins and minerals as a public health strategy Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/354783). Licence: CC BY-NC-SA 3.0 IGO.
  143. Guideline: fortification of rice with vitamins and minerals as a public health strategy. Geneva: World Health Organization; 2018 (https://iris.who.int/handle/10665/272535). Licence: CC BY-NC-SA 3.0 IGO.
  144. Fortification of maize flour and corn meal with vitamins and minerals. Geneva: World Health Organization; 2016 (https://iris.who.int/handle/10665/251902). Licence: CC BY-NC-SA 3.0 IGO.
  145. Ritu G, Gupta A. Fortification of foods with vitamin D in India. Nutrients. 2014;6:3601–23 (https://doi.org/10.3390/nu6093601).
  146. Yang Z, Laillou A, Smith G, Schofield D, Moench-Pfanner R. A review of vitamin D fortification: implications for nutrition programming in Southeast Asia. Food Nutr Bull. 2013;34:S81–9 (https://doi.org/10.1177/15648265130342S110).
  147. Closing the gap in a generation: health equity through action on the social determinants of health: final report of the Commission on Social Determinants of Health. Geneva: World Health Organization; 2008 (https://iris.who.int/handle/10665/43943).
  148. Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JD. The social determinants of tuberculosis: from evidence to action. Am J Public Health. 2011;101:654–62 (https://doi.org/10.2105/AJPH.2010.199505).
  149. World Health Organization, Centers for Disease Control and Prevention, UNHCR. Tuberculosis prevention and care among refugees and other populations in humanitarian settings: an interagency field guide. Geneva: World Health Organization; 2022 (https://iris.who.int/handle/10665/352283). Licence: CC BY-NC-SA 3.0 IGO.
  150. WHO operational handbook on tuberculosis. Module 2: screening – systematic screening for tuberculosis disease. Geneva: World Health Organization; 2021 (https://iris.who.int/handle/10665/340256). Licence: CC BY-NC-SA 3.0 IGO.
  151. Guidance on evidence generation on new regimens for tuberculosis treatment. Geneva: World Health Organization; 2024 (https://iris.who.int/handle/10665/379830). Licence: CC BY-NC-SA 3.0 IGO.

13 All references were accessed on 7 May 2025.

Navegación del libro